Evidence map›Paper›PMID 30275084›Full record

ArticleAntimicrobial agents and chemotherapy2018

Selective Inhibition of

Jonathan D Lenz, Kristina A Shirk, Adrienne Jolicoeur, Joseph P Dillard

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Repurposing salicylamide for combating multidrug-resistantAntimicrobial agents and chemotherapy · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jonathan D LenzDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-2637-9720
Kristina A ShirkDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Adrienne JolicoeurDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Joseph P DillardDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA jpdillard@wisc.edu.
University of Wisconsin–Madison · US

Funding

Peptidoglycan metabolism and fragment releaseR01AI097157 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI DILLARD, JOSEPH P · 2012 to 2022
$5.6M
Microbial Pathogenesis &Host Responses Training ProgramT32AI055397 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN · 2003 to 2024
$5.5M
Outer membrane vesicles and peptidoglycan of Neisseria gonorrhoeaeF32AI115911 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LENZ, JONATHAN DAVID · 2015 to 2016
$112k
NIAID NIH HHS F32 AI115911NIAID NIH HHS R01 AI097157NIAID NIH HHS T32 AI055397
6 · The paper itself

Abstract

The Gram-negative human pathogen

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCarboxypeptidases ACell SurvivalCell WallGene ExpressionHCT116 CellsHumansInterleukin-8Lactobacillus gasseriMicrobial Sensitivity TestsMicrobial ViabilityMutationNeisseria gonorrhoeaePeptidoglycanProbioticsAnti-Bacterial AgentsBacterial ProteinsCarboxypeptidases ACXCL8 protein, humanInterleukin-8PeptidoglycanThiazolesantibiotic resistanceantimicrobial agentsinflammationLactobacillusmicrobial communitiesNeisseria gonorrhoeaepeptidoglycan

Identifiers

PMID30275084
PMCPMC6256793
OpenAlexW2892417888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.